Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Human vaccines & immunotherapeutics: News October 2022156
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China107
Vaccine manufacturing is essential to ensure access103
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’102
Human vaccines and immunotherapeutics: News December 202395
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia87
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She84
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria73
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study73
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling73
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies66
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu63
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study63
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)62
Determinants of basic childhood vaccination coverage in European and OECD countries59
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary58
Enhancing COVID-19 booster vaccination among the elderly through text message reminders58
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control56
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam56
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence55
Correction54
Acute encephalitis after COVID-19 vaccination: A case report and literature review54
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with51
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector50
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202148
Bacteriophages as vaccine platforms: Opportunities and challenges in translation47
PV-10 enhances immune responses in hepatitis B vaccination through STING pathway46
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children45
HV&I Reviewer Highlight41
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents40
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities40
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak40
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality39
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons39
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children39
How to make effective HPV vaccine recommendations starting at age 938
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain38
0.21454906463623